Logo

Diamond Healthcare, AssureRx Team on Personalized Medicine Program for Behavioral Health

Sep 18, 2008
NEW YORK (GenomeWeb News) – AssureRx and Diamond Healthcare will collaborate on a personalized medicine platform for use by physicians treating patients with behavioral health conditions, AssureRx said today.
 
Through the alliance, AssureRx will gain access to the managerial and clinical expertise and industry relationships of Diamond Healthcare, which provides behavioral health management and consulting services, to help develop its first commercial product for the behavioral health market.
 
Cincinnati-based AssureRx is developing products based on pharmacogenetics to help guide physicians in making treatment decisions. The platform is based on technology licensed from the Mayo Clinic and the Cincinnati Children’s Hospital.
 
As part of the alliance with Diamond, George White, president of Diamond Healthcare, has joined AssureRx’s board of directors.

Breaking News
The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.